Oxford BioDynamics Plc
OBD.L · LSE
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £0 | £0 | £0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | -13.5% | 90% | -5.5% | – |
| Gross Profit | -£0 | -£0 | -£0 | -£0 |
| % Margin | -604.7% | -524.2% | -1,073.1% | -1,183.5% |
| EBITDA | -£0 | -£0 | -£0 | -£0 |
| % Margin | -936.4% | -859.3% | -1,920.7% | -1,232.4% |
| Net Income | -£0 | -£0 | -£0 | -£0 |
| % Margin | -1,063.4% | -979.7% | -2,214.2% | -1,445% |
| EPS Diluted | -0.003 | -0.007 | -0.022 | -0.023 |
| % Growth | 58.8% | 68.9% | 6.4% | – |
| Operating Cash Flow | -£0 | -£0 | -£0 | -£0 |
| Capital Expenditures | -£0 | £0 | -£0 | -£0 |
| Free Cash Flow | -£0 | -£0 | -£0 | -£0 |